Fighting Blindness Canada

AMD Clinical Trial Update on Next-GEN Anti-VEGF Treatment

Roche has released the results of a Phase 3 trial of a next-generation anti-VEGF treatment, faricimab, for wet age-related macular degeneration (wet...

Read More
Fighting Blindness Canada research

Cholesterol Lowering Statin Drug May Promote Retinal Neuron Regeneration

FBC funded researcher Dr Philippe Monnier has published a study in the journal Neurobiology of Disease that shows that cholesterol inhibition...

Read More
Hoya Vision Care Canada logo

HOYA Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study

HOYA Vision Care announced during the European Academy of Optometrists and Optics (AOO21) the results of a three-year follow-up clinical study on...

Read More

Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03

Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...

Read More
Fighting Blindness Canada research

Gene Therapy Approach to Regenerate Damaged Optic Nerves

Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this...

Read More
1 12 13 14 15 16 51